Immix Biopharma, Inc.
IMMX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $62,228 | $120,000 | $30,294 | $47,094 |
| - Cash | $17,682 | $17,510 | $13,437 | $17,644 |
| + Debt | $1,075 | $0 | $0 | $50 |
| Enterprise Value | $45,621 | $102,490 | $16,857 | $29,500 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$22,559 | -$16,136 | -$8,217 | -$24,196 |
| % Margin | – | – | – | – |
| Net Income | -$21,613 | -$15,426 | -$8,230 | -$24,384 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.76 | -0.89 | -0.59 | -6.64 |
| % Growth | 14.6% | -50.8% | 91.1% | – |
| Operating Cash Flow | -$14,595 | -$11,371 | -$7,408 | -$1,589 |
| Capital Expenditures | -$1,178 | -$52 | $0 | -$1 |
| Free Cash Flow | -$15,773 | -$11,424 | -$7,408 | -$1,590 |